{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:52:13Z","timestamp":1793130733477,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82471261\uff1b82101325"],"award-info":[{"award-number":["82471261\uff1b82101325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangzhou basic and applied basic research foundation","award":["2024A04J3540"],"award-info":[{"award-number":["2024A04J3540"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03997-5","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T03:03:59Z","timestamp":1767755039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["RVG-targeted extracellular vesicles loaded with echinatin attenuate dopaminergic neurodegeneration via the IGF-2\/PI3K\/Akt pathway in Parkinson\u2019s disease mice"],"prefix":"10.1186","volume":"24","author":[{"given":"Liuyan","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongtang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshu","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"3997_CR1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1056\/NEJMra2401857","volume":"391","author":"CM Tanner","year":"2024","unstructured":"Tanner CM, Ostrem JL, Ropper AH. Parkinson\u2019s Disease. N Engl J Med. 2024;391:442\u201352. https:\/\/doi.org\/10.1056\/NEJMra2401857.","journal-title":"N Engl J Med"},{"key":"3997_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386:896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3.","journal-title":"Lancet"},{"key":"3997_CR3","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier DJ. Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J. 2018;285:3657\u201368. https:\/\/doi.org\/10.1111\/febs.14607.","journal-title":"FEBS J"},{"key":"3997_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s11064-021-03464-1","volume":"47","author":"AK Mishra","year":"2022","unstructured":"Mishra AK, Dixit A. Dopaminergic axons: key recitalists in Parkinson\u2019s disease. Neurochem Res. 2022;47:234\u201348. https:\/\/doi.org\/10.1007\/s11064-021-03464-1.","journal-title":"Neurochem Res"},{"key":"3997_CR5","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/brain\/awaa181","volume":"143","author":"R Cilia","year":"2020","unstructured":"Cilia R, Cereda E, Akpalu A, Sarfo FS, Cham M, Laryea R, et al. Natural history of motor symptoms in Parkinson\u2019s disease and the long-duration response to Levodopa. Brain. 2020;143:2490\u2013501. https:\/\/doi.org\/10.1093\/brain\/awaa181.","journal-title":"Brain"},{"key":"3997_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11306-024-02181-4","volume":"20","author":"X Flores-Ponce","year":"2024","unstructured":"Flores-Ponce X, Velasco I. Dopaminergic neuron metabolism: relevance for understanding Parkinson\u2019s disease. Metabolomics. 2024;20:116. https:\/\/doi.org\/10.1007\/s11306-024-02181-4.","journal-title":"Metabolomics"},{"key":"3997_CR7","doi-asserted-by":"publisher","first-page":"C641","DOI":"10.1152\/ajpcell.00222.2006","volume":"292","author":"O Kann","year":"2007","unstructured":"Kann O, Kov\u00e1cs R. Mitochondria and neuronal activity. Am J Physiol-Cell Physiol. 2007;292:C641-57. https:\/\/doi.org\/10.1152\/ajpcell.00222.2006.","journal-title":"Am J Physiol-Cell Physiol"},{"key":"3997_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3892\/ijmm.2017.3255","volume":"41","author":"X Liu","year":"2017","unstructured":"Liu X, Wang Y, Yu X, Li D, Li G. Mitochondria-mediated damage to dopaminergic neurons in Parkinson\u2019s disease (Review). Int J Mol Med. 2017;41:615\u201323. https:\/\/doi.org\/10.3892\/ijmm.2017.3255.","journal-title":"Int J Mol Med"},{"key":"3997_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fnmol.2020.00116","volume":"13","author":"MA Hannan","year":"2020","unstructured":"Hannan MA, Dash R, Sohag AAM, Haque MN, Moon IS. Neuroprotection against oxidative stress: phytochemicals targeting TrkB signaling and the Nrf2-ARE antioxidant system. Front Mol Neurosci. 2020;13:116. https:\/\/doi.org\/10.3389\/fnmol.2020.00116.","journal-title":"Front Mol Neurosci"},{"key":"3997_CR10","doi-asserted-by":"publisher","first-page":"154582","DOI":"10.1016\/j.phymed.2022.154582","volume":"109","author":"X Bai","year":"2023","unstructured":"Bai X, Bian Z, Zhang M. Targeting the Nrf2 signaling pathway using phytochemical ingredients: a novel therapeutic road map to combat neurodegenerative diseases. Phytomedicine. 2023;109:154582. https:\/\/doi.org\/10.1016\/j.phymed.2022.154582.","journal-title":"Phytomedicine"},{"key":"3997_CR11","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.3390\/cimb46060352","volume":"46","author":"NA Alsharairi","year":"2024","unstructured":"Alsharairi NA. The role of licorice chalcones as molecular genes and signaling pathways modulator\u2014a review of experimental implications for Nicotine-Induced Non-Small cell lung cancer treatment. Curr Issues Mol Biol. 2024;46:5894\u2013908. https:\/\/doi.org\/10.3390\/cimb46060352.","journal-title":"Curr Issues Mol Biol"},{"key":"3997_CR12","doi-asserted-by":"publisher","unstructured":"Wu Y, Wang Z, Du Q, Zhu Z, Chen T, Xue Y et al. Pharmacological Effects and Underlying Mechanisms of Licorice-Derived Flavonoids. Chen J, editor. Evidence-Based Complementary and Alternative Medicine. 2022;2022:1\u201325. https:\/\/doi.org\/10.1155\/2022\/9523071","DOI":"10.1155\/2022\/9523071"},{"key":"3997_CR13","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.3390\/ijms21144875","volume":"21","author":"A Gugliandolo","year":"2020","unstructured":"Gugliandolo A, Bramanti P, Mazzon E. Activation of Nrf2 by natural bioactive compounds: a promising approach for stroke? IJMS. 2020;21:4875. https:\/\/doi.org\/10.3390\/ijms21144875.","journal-title":"IJMS"},{"key":"3997_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood\u2013brain barrier: structure, regulation and drug delivery. Signal Transduct Target Ther. 2023;8:217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w.","journal-title":"Signal Transduct Target Ther"},{"key":"3997_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40820-022-00847-z","volume":"14","author":"G Cheng","year":"2022","unstructured":"Cheng G, Liu Y, Ma R, Cheng G, Guan Y, Chen X, et al. Anti-Parkinsonian therapy: strategies for crossing the Blood\u2013Brain barrier and nano-biological effects of nanomaterials. Nano-Micro Lett. 2022;14:105. https:\/\/doi.org\/10.1007\/s40820-022-00847-z.","journal-title":"Nano-Micro Lett"},{"key":"3997_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4103\/ajprhc.ajprhc_88_24","volume":"16","author":"F Alheibshy","year":"2024","unstructured":"Alheibshy F. The use of nano-based drug delivery systems for neurodegenerative disorders. Asian Journal of Pharmaceutical Research and Health Care. 2024;16:267\u201371. https:\/\/doi.org\/10.4103\/ajprhc.ajprhc_88_24.","journal-title":"Asian Journal of Pharmaceutical Research and Health Care"},{"key":"3997_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jtice.2018.03.028","volume":"87","author":"Y-C Kuo","year":"2018","unstructured":"Kuo Y-C, Rajesh R. Current development of nanocarrier delivery systems for parkinson\u2019s disease pharmacotherapy. J Taiwan Inst Chem Eng. 2018;87:15\u201325. https:\/\/doi.org\/10.1016\/j.jtice.2018.03.028.","journal-title":"J Taiwan Inst Chem Eng"},{"key":"3997_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol. 2021;16:748\u201359. https:\/\/doi.org\/10.1038\/s41565-021-00931-2.","journal-title":"Nat Nanotechnol"},{"key":"3997_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.procbio.2019.06.025","volume":"85","author":"N Seyfizadeh","year":"2019","unstructured":"Seyfizadeh N, Seyfizadeh N, Borzouisileh S, Elahimanesh F, Hosseini V, Nouri M. Exosome-mediated therapeutic delivery: a new horizon for human neurodegenerative disorders\u2019 treatment (with a focus on SiRNA delivery improvement). Process Biochem. 2019;85:164\u201374. https:\/\/doi.org\/10.1016\/j.procbio.2019.06.025.","journal-title":"Process Biochem"},{"key":"3997_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114968","volume":"199","author":"M Imran Sajid","year":"2023","unstructured":"Imran Sajid M, Sultan Sheikh F, Anis F, Nasim N, Sumbria RK, Nauli SM, et al. siRNA drug delivery across the blood\u2013brain barrier in Alzheimer\u2019s disease. Adv Drug Deliv Rev. 2023;199:114968. https:\/\/doi.org\/10.1016\/j.addr.2023.114968.","journal-title":"Adv Drug Deliv Rev"},{"key":"3997_CR21","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","volume":"18","author":"S Zha","year":"2024","unstructured":"Zha S, Liu H, Li H, Li H, Wong K-L, All AH. Functionalized nanomaterials capable of crossing the blood-brain barrier. ACS Nano. 2024;18:1820\u201345. https:\/\/doi.org\/10.1021\/acsnano.3c10674.","journal-title":"ACS Nano"},{"key":"3997_CR22","doi-asserted-by":"publisher","unstructured":"Mulcahy LA, Pink RC, Carter DRF. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3. https:\/\/doi.org\/10.3402\/jev.v3.24641.","DOI":"10.3402\/jev.v3.24641"},{"key":"3997_CR23","doi-asserted-by":"publisher","first-page":"42045","DOI":"10.1021\/acsomega.3c04862","volume":"8","author":"J Burns","year":"2023","unstructured":"Burns J, Buck AC, D\u2019 Souza S, Dube A, Bardien S. Nanophytomedicines as therapeutic agents for parkinson\u2019s disease. ACS Omega. 2023;8:42045\u201361. https:\/\/doi.org\/10.1021\/acsomega.3c04862.","journal-title":"ACS Omega"},{"key":"3997_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson\u2019s disease. Nat Protoc. 2007;2:141\u201351. https:\/\/doi.org\/10.1038\/nprot.2006.342.","journal-title":"Nat Protoc"},{"key":"3997_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2174\/187152712800792848","volume":"11","author":"M Shahnawaz Khan","year":"2012","unstructured":"Shahnawaz Khan M, Tabrez S, Priyadarshini M, Priyamvada S, Khan M. Targeting Parkinson\u2019s - Tyrosine hydroxylase and oxidative stress as points of interventions. CNSNDDT. 2012;11:369\u201380. https:\/\/doi.org\/10.2174\/187152712800792848.","journal-title":"CNSNDDT"},{"key":"3997_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/mds.870120609","volume":"12","author":"JN Joyce","year":"1997","unstructured":"Joyce JN, Smutzer G, Whitty CJ, Myers A, Bannon MJ. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with parkinson\u2019s, alzheimer\u2019s with parkinsonism, and alzheimer\u2019s disease. Mov Disord. 1997;12:885\u201397. https:\/\/doi.org\/10.1002\/mds.870120609.","journal-title":"Mov Disord"},{"key":"3997_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.37360\/blacpma.25.24.2.12","volume":"24","author":"X Du","year":"2025","unstructured":"Du X. Modulation of the PI3K\/AKT pathway by using traditional Chinese medicines in treating parkinson\u2019s disease: a review of animal model studies. Bol Latinoam Caribe Plantas Med Aromat. 2025;24:172\u201385. https:\/\/doi.org\/10.37360\/blacpma.25.24.2.12.","journal-title":"Bol Latinoam Caribe Plantas Med Aromat"},{"key":"3997_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neulet.2016.01.029","volume":"615","author":"N Yal\u00e7\u0131nkaya","year":"2016","unstructured":"Yal\u00e7\u0131nkaya N, Haytural H, Bilgi\u00e7 B, \u00d6zdemir \u00d6, Hana\u011fas\u0131 H, K\u00fc\u00e7\u00fckali C\u0130, et al. Expression changes of genes associated with apoptosis and survival processes in Parkinson\u2019s disease. Neurosci Lett. 2016;615:72\u20137. https:\/\/doi.org\/10.1016\/j.neulet.2016.01.029.","journal-title":"Neurosci Lett"},{"key":"3997_CR29","doi-asserted-by":"publisher","first-page":"153664","DOI":"10.1016\/j.phymed.2021.153664","volume":"91","author":"S Fakhri","year":"2021","unstructured":"Fakhri S, Iranpanah A, Gravandi MM, Moradi SZ, Ranjbari M, Majnooni MB, et al. Natural products attenuate PI3K\/Akt\/mTOR signaling pathway: a promising strategy in regulating neurodegeneration. Phytomedicine. 2021;91:153664. https:\/\/doi.org\/10.1016\/j.phymed.2021.153664.","journal-title":"Phytomedicine"},{"key":"3997_CR30","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1073\/pnas.040556597","volume":"97","author":"A Hartmann","year":"2000","unstructured":"Hartmann A, Hunot S, Michel PP, Muriel M-P, Vyas S, Faucheux BA, et al. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2000;97:2875\u201380. https:\/\/doi.org\/10.1073\/pnas.040556597.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3997_CR31","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1002\/ana.10489","volume":"53","author":"WG Tatton","year":"2003","unstructured":"Tatton WG, Chalmers-Redman R, Brown D, Tatton N. Apoptosis in parkinson\u2019s disease: signals for neuronal degradation. Ann Neurol. 2003;53:S61\u201372. https:\/\/doi.org\/10.1002\/ana.10489.","journal-title":"Ann Neurol"},{"key":"3997_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/0022-510x(95)00336-z","volume":"137","author":"H Mochizuki","year":"1996","unstructured":"Mochizuki H, Goto K, Mori H, Mizuno Y. Histochemical detection of apoptosis in parkinson\u2019s disease. J Neurol Sci. 1996;137:120\u20133. https:\/\/doi.org\/10.1016\/0022-510x(95)00336-z.","journal-title":"J Neurol Sci"},{"key":"3997_CR33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1365-2990.1995.tb01096.x","volume":"21","author":"D Troost","year":"1995","unstructured":"Troost D, Aten J, Morsink F, De Jong JMBV. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post\u2010central gyrus. Neuropathol Appl Neurobiol. 1995;21:498\u2013504. https:\/\/doi.org\/10.1111\/j.1365-2990.1995.tb01096.x.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3997_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01175-9","volume":"7","author":"C Su","year":"2024","unstructured":"Su C, Hou Y, Xu J, Xu Z, Zhou M, Ke A, et al. Identification of Parkinson\u2019s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data. NPJ Digit Med. 2024;7:184. https:\/\/doi.org\/10.1038\/s41746-024-01175-9.","journal-title":"NPJ Digit Med"},{"key":"3997_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jep.2017.01.001","volume":"206","author":"A De Rus Jacquet","year":"2017","unstructured":"De Rus Jacquet A, Tambe MA, Ma SY, McCabe GP, Vest JHC, Rochet J-C. Pikuni-Blackfeet traditional medicine: neuroprotective activities of medicinal plants used to treat Parkinson\u2019s disease-related symptoms. J Ethnopharmacol. 2017;206:393\u2013407. https:\/\/doi.org\/10.1016\/j.jep.2017.01.001.","journal-title":"J Ethnopharmacol"},{"key":"3997_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00014","volume":"9","author":"C Monti","year":"2015","unstructured":"Monti C, Bondi H, Urbani A, Fasano M, Alberio T. Systems biology analysis of the proteomic alterations induced by MPP+, a Parkinson\u2019s disease-related mitochondrial toxin. Front Cell Neurosci. 2015;9:14. https:\/\/doi.org\/10.3389\/fncel.2015.00014.","journal-title":"Front Cell Neurosci"},{"key":"3997_CR37","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1210\/edrv.22.6.0452","volume":"22","author":"J Nakae","year":"2001","unstructured":"Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev. 2001;22:818\u201335. https:\/\/doi.org\/10.1210\/edrv.22.6.0452.","journal-title":"Endocr Rev"},{"key":"3997_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010234","volume":"23","author":"S D\u00edaz Del Moral","year":"2021","unstructured":"D\u00edaz Del Moral S, Benaouicha M, Mu\u00f1oz-Ch\u00e1puli R, Carmona R. The insulin-like growth factor signalling pathway in cardiac development and regeneration. Int J Mol Sci. 2021;23:234. https:\/\/doi.org\/10.3390\/ijms23010234.","journal-title":"Int J Mol Sci"},{"key":"3997_CR39","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.str.2020.05.002","volume":"28","author":"Y Xu","year":"2020","unstructured":"Xu Y, Kirk NS, Venugopal H, Margetts MB, Croll TI, Sandow JJ, et al. How IGF-II binds to the human type 1 insulin-like growth factor receptor. Structure. 2020;28:786-798.e6. https:\/\/doi.org\/10.1016\/j.str.2020.05.002.","journal-title":"Structure"},{"key":"3997_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12030629","volume":"12","author":"N Lee","year":"2023","unstructured":"Lee N, Youn K, Yoon J-H, Lee B, Kim DH, Jun M. The role of fucoxanthin as a potent Nrf2 activator via akt\/GSK-3\u03b2\/fyn axis against amyloid-\u03b2 peptide-induced oxidative damage. Antioxidants (Basel). 2023;12:629. https:\/\/doi.org\/10.3390\/antiox12030629.","journal-title":"Antioxidants (Basel)"},{"key":"3997_CR41","doi-asserted-by":"publisher","first-page":"e11903","DOI":"10.7554\/eLife.11903","volume":"5","author":"X Guo","year":"2016","unstructured":"Guo X, Snider WD, Chen B. GSK3\u03b2 regulates AKT-induced central nervous system axon regeneration via an eIF2B\u03b5-dependent, mTORC1-independent pathway. Elife. 2016;5:e11903. https:\/\/doi.org\/10.7554\/eLife.11903.","journal-title":"Elife"},{"key":"3997_CR42","doi-asserted-by":"publisher","first-page":"11960","DOI":"10.1073\/pnas.220413597","volume":"97","author":"X Fang","year":"2000","unstructured":"Fang X, Yu SX, Lu Y, Bast RC, Woodgett JR, Mills GB. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A. 2000;97:11960\u20135. https:\/\/doi.org\/10.1073\/pnas.220413597.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3997_CR43","doi-asserted-by":"publisher","first-page":"688","DOI":"10.34172\/apb.2023.071","volume":"13","author":"SR Shri","year":"2023","unstructured":"Shri SR, Manandhar S, Nayak Y, Pai KSR. Role of GSK-3\u03b2 inhibitors: new promises and opportunities for Alzheimer\u2019s disease. Adv Pharm Bull. 2023;13:688\u2013700. https:\/\/doi.org\/10.34172\/apb.2023.071.","journal-title":"Adv Pharm Bull"},{"key":"3997_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A. AKT\/PKB signaling: navigating the network. Cell. 2017;169:381\u2013405. https:\/\/doi.org\/10.1016\/j.cell.2017.04.001.","journal-title":"Cell"},{"key":"3997_CR45","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708604","volume":"10","author":"P Ranea-Robles","year":"2018","unstructured":"Ranea-Robles P, Launay N, Ruiz M, Calingasan NY, Dumont M, Naud\u00ed A, et al. <article-title update=\"added\"> Aberrant regulation of the <scp>GSK<\/scp> \u20103\u03b2\/ <scp>NRF<\/scp> 2 axis unveils a novel therapy for adrenoleukodystrophy. EMBO Mol Med. 2018;10:e8604. https:\/\/doi.org\/10.15252\/emmm.201708604.","journal-title":"EMBO Mol Med"},{"key":"3997_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41420-025-02491-z","volume":"11","author":"X Yang","year":"2025","unstructured":"Yang X, Liu Y, Cao J, Wu C, Tang L, Bian W, et al. Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment. Cell Death Discov. 2025;11:189. https:\/\/doi.org\/10.1038\/s41420-025-02491-z.","journal-title":"Cell Death Discov"},{"key":"3997_CR47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s43440-022-00390-z","volume":"74","author":"D Soni","year":"2022","unstructured":"Soni D, Kumar P. GSK-3\u03b2-mediated regulation of Nrf2\/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders. Pharmacol Rep. 2022;74:557\u201369. https:\/\/doi.org\/10.1007\/s43440-022-00390-z.","journal-title":"Pharmacol Rep"},{"key":"3997_CR48","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell. 2016;167:1469-1480.e12. https:\/\/doi.org\/10.1016\/j.cell.2016.11.018.","journal-title":"Cell"},{"key":"3997_CR49","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","volume":"18","author":"AH Tan","year":"2022","unstructured":"Tan AH, Lim SY, Lang AE. The microbiome\u2013gut\u2013brain axis in Parkinson disease \u2014 from basic research to the clinic. Nat Rev Neurol. 2022;18:476\u201395. https:\/\/doi.org\/10.1038\/s41582-022-00681-2.","journal-title":"Nat Rev Neurol"},{"key":"3997_CR50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jare.2022.10.013","volume":"50","author":"S Salim","year":"2023","unstructured":"Salim S, Ahmad F, Banu A, Mohammad F. Gut microbiome and Parkinson\u2019s disease: perspective on pathogenesis and treatment. J Adv Res. 2023;50:83\u2013105. https:\/\/doi.org\/10.1016\/j.jare.2022.10.013.","journal-title":"J Adv Res"},{"key":"3997_CR51","doi-asserted-by":"publisher","first-page":"7328","DOI":"10.1038\/s41598-017-06767-y","volume":"7","author":"S Saiki","year":"2017","unstructured":"Saiki S, Hatano T, Fujimaki M, Ishikawa K-I, Mori A, Oji Y, et al. Decreased long-chain acylcarnitines from insufficient \u03b2-oxidation as potential early diagnostic markers for parkinson\u2019s disease. Sci Rep. 2017;7:7328. https:\/\/doi.org\/10.1038\/s41598-017-06767-y.","journal-title":"Sci Rep"},{"key":"3997_CR52","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41467-021-21669-4","volume":"12","author":"E Sinclair","year":"2021","unstructured":"Sinclair E, Trivedi DK, Sarkar D, Walton-Doyle C, Milne J, Kunath T, et al. Metabolomics of sebum reveals lipid dysregulation in parkinson\u2019s disease. Nat Commun. 2021;12:1592. https:\/\/doi.org\/10.1038\/s41467-021-21669-4.","journal-title":"Nat Commun"},{"key":"3997_CR53","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/jnnp-2014-309676","volume":"87","author":"T Hatano","year":"2016","unstructured":"Hatano T, Saiki S, Okuzumi A, Mohney RP, Hattori N. Identification of novel biomarkers for parkinson\u2019s disease by metabolomic technologies. J Neurol Neurosurg Psychiatry. 2016;87:295\u2013301. https:\/\/doi.org\/10.1136\/jnnp-2014-309676.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3997_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105663","volume":"166","author":"ME Gegg","year":"2022","unstructured":"Gegg ME, Menozzi E, Schapira AHV. Glucocerebrosidase-associated Parkinson disease: pathogenic mechanisms and potential drug treatments. Neurobiol Dis. 2022;166:105663. https:\/\/doi.org\/10.1016\/j.nbd.2022.105663.","journal-title":"Neurobiol Dis"},{"key":"3997_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2671070","volume":"2020","author":"S Mawatari","year":"2020","unstructured":"Mawatari S, Ohara S, Taniwaki Y, Tsuboi Y, Maruyama T, Fujino T. Improvement of blood plasmalogens and clinical symptoms in parkinson\u2019s disease by oral administration of ether phospholipids: a preliminary report. Parkinsons Dis. 2020;2020:1\u20137. https:\/\/doi.org\/10.1155\/2020\/2671070.","journal-title":"Parkinsons Dis"},{"key":"3997_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136428","volume":"769","author":"EA Ostrakhovitch","year":"2022","unstructured":"Ostrakhovitch EA, Song E-S, Macedo JKA, Gentry MS, Quintero JE, Van Horne C, et al. Analysis of circulating metabolites to differentiate Parkinson\u2019s disease and essential tremor. Neurosci Lett. 2022;769:136428. https:\/\/doi.org\/10.1016\/j.neulet.2021.136428.","journal-title":"Neurosci Lett"},{"key":"3997_CR57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/gut.28.2.181","volume":"28","author":"OH Nielsen","year":"1987","unstructured":"Nielsen OH, Ahnfelt-Ronne I, Elmgreen J. Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophils. Gut. 1987;28:181\u20135. https:\/\/doi.org\/10.1136\/gut.28.2.181.","journal-title":"Gut"},{"key":"3997_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jms.4781","volume":"56","author":"J Zhang","year":"2021","unstructured":"Zhang J, Liu L, Zhang L, Chen S, Chen Y, Cai C. Targeted fatty acid metabolomics to discover Parkinson\u2019s disease associated metabolic alteration. J Mass Spectrom. 2021;56:e4781. https:\/\/doi.org\/10.1002\/jms.4781.","journal-title":"J Mass Spectrom"},{"key":"3997_CR59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41420-023-01549-0","volume":"9","author":"W Zhang","year":"2023","unstructured":"Zhang W, Chen S, Huang X, Tong H, Niu H, Lu L. Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced parkinson\u2019s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome. Cell Death Discov. 2023;9:251. https:\/\/doi.org\/10.1038\/s41420-023-01549-0.","journal-title":"Cell Death Discov"},{"key":"3997_CR60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.06.003","volume":"65","author":"D Pietrucci","year":"2019","unstructured":"Pietrucci D, Cerroni R, Unida V, Farcomeni A, Pierantozzi M, Mercuri NB, et al. Dysbiosis of gut microbiota in a selected population of Parkinson\u2019s patients. Parkinsonism Relat Disord. 2019;65:124\u201330. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.003.","journal-title":"Parkinsonism Relat Disord"},{"key":"3997_CR61","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/CM9.0000000000003318","volume":"138","author":"L Wang","year":"2025","unstructured":"Wang L, Cui Y, Han B, Du Y, Salewala KS, Wang S, et al. Gut microbiota and Parkinson\u2019s disease. Chin Med J (Engl). 2025;138:289\u201397. https:\/\/doi.org\/10.1097\/CM9.0000000000003318.","journal-title":"Chin Med J (Engl)"},{"key":"3997_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3130","volume":"13","author":"AO Omotosho","year":"2023","unstructured":"Omotosho AO, Tajudeen YA, Oladipo HJ, Yusuff SI, AbdulKadir M, Muili AO, et al. Parkinson\u2019s disease: are gut microbes involved? Brain Behav. 2023;13:e3130. https:\/\/doi.org\/10.1002\/brb3.3130.","journal-title":"Brain Behav"},{"key":"3997_CR63","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12866-023-02933-7","volume":"23","author":"M Mehanna","year":"2023","unstructured":"Mehanna M, AbuRaya S, Ahmed SM, Ashmawy G, Ibrahim A, AbdelKhaliq E. Study of the gut microbiome in Egyptian patients with parkinson\u2019s disease. BMC Microbiol. 2023;23:196. https:\/\/doi.org\/10.1186\/s12866-023-02933-7.","journal-title":"BMC Microbiol"},{"key":"3997_CR64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. Meta-analysis of the parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 2021;7:27. https:\/\/doi.org\/10.1038\/s41531-021-00156-z.","journal-title":"NPJ Parkinsons Dis"},{"key":"3997_CR65","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3390\/neurolint15020047","volume":"15","author":"AC Proano","year":"2023","unstructured":"Proano AC, Viteri JA, Orozco EN, Calle MA, Costa SC, Reyes DV, et al. Gut microbiota and its repercussion in Parkinson\u2019s disease: a systematic review in Occidental patients. Neurol Int. 2023;15:750\u201363. https:\/\/doi.org\/10.3390\/neurolint15020047.","journal-title":"Neurol Int"},{"key":"3997_CR66","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/ijms26041676","volume":"26","author":"L Liu","year":"2025","unstructured":"Liu L, Zhao Y, Yang W, Han L, Mo X, Sheng J, et al. Correlations between amelioration of rotenone-induced parkinson\u2019s symptoms by amomum Tsaoko flavonoids and gut microbiota in mice. IJMS. 2025;26:1676. https:\/\/doi.org\/10.3390\/ijms26041676.","journal-title":"IJMS"},{"key":"3997_CR67","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3390\/life13040957","volume":"13","author":"S Mitra","year":"2023","unstructured":"Mitra S, Munni YA, Dash R, Sadhu T, Barua L, Islam MA, et al. Gut microbiota in autophagy regulation: new therapeutic perspective in neurodegeneration. Life. 2023;13:957. https:\/\/doi.org\/10.3390\/life13040957.","journal-title":"Life"},{"key":"3997_CR68","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3390\/biomedicines10071486","volume":"10","author":"L Ghezzi","year":"2022","unstructured":"Ghezzi L, Cantoni C, Rotondo E, Galimberti D. The gut Microbiome\u2013Brain crosstalk in neurodegenerative diseases. Biomedicines. 2022;10:1486. https:\/\/doi.org\/10.3390\/biomedicines10071486.","journal-title":"Biomedicines"},{"key":"3997_CR69","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.3390\/nu15214631","volume":"15","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Bonfili L, Wei T, Eleuteri AM. Understanding the Gut\u2013Brain axis and its therapeutic implications for neurodegenerative disorders. Nutrients. 2023;15:4631. https:\/\/doi.org\/10.3390\/nu15214631.","journal-title":"Nutrients"},{"key":"3997_CR70","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361. https:\/\/doi.org\/10.1002\/jcc.21334.","journal-title":"J Comput Chem"},{"key":"3997_CR71","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12951-021-01148-0","volume":"19","author":"T Zhu","year":"2021","unstructured":"Zhu T, Xiao Y, Meng X, Tang L, Li B, Zhao Z, et al. Nanovesicles derived from bispecific CAR-T cells targeting the Spike protein of SARS-CoV-2 for treating COVID-19. J Nanobiotechnol. 2021;19:391. https:\/\/doi.org\/10.1186\/s12951-021-01148-0.","journal-title":"J Nanobiotechnol"},{"key":"3997_CR72","unstructured":"National Research Council (US) Committee for the Update of the Guide for theCare and Use of Laboratory Animals. Guide for the care and use of laboratory animals [Internet]. 8th ed. Washington (DC): National Academies Press (US). 2011 [cited 2025 Oct 13]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK54050\/. Accessed 13 Oct 2025."},{"key":"3997_CR73","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1021\/acschemneuro.9b00609","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Meng X, Jiao Z, Liu Y, Zhang X, Qu S. Generation of a novel mouse model of parkinson\u2019s disease via targeted knockdown of glutamate transporter GLT-1 in the substantia Nigra. ACS Chem Neurosci. 2020;11:406\u201317. https:\/\/doi.org\/10.1021\/acschemneuro.9b00609.","journal-title":"ACS Chem Neurosci"},{"key":"3997_CR74","doi-asserted-by":"publisher","first-page":"e2574","DOI":"10.1038\/cddis.2016.454","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, He X, Meng X, Wu X, Tong H, Zhang X, et al. Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson\u2019s disease model. Cell Death Dis. 2017;8:e2574\u2013e2574. https:\/\/doi.org\/10.1038\/cddis.2016.454.","journal-title":"Cell Death Dis"},{"key":"3997_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115381","volume":"44","author":"R Noorizadeh","year":"2025","unstructured":"Noorizadeh R, Sax B, Javaheri T, Radic-Sarikas B, Fock V, Suresh V, et al. YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1-mediated reprogramming of bone mesenchymal stem cells. Cell Rep. 2025;44:115381. https:\/\/doi.org\/10.1016\/j.celrep.2025.115381.","journal-title":"Cell Rep"},{"key":"3997_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405364","volume":"11","author":"W Zhang","year":"2024","unstructured":"Zhang W, Ren J, Ding L, Zheng S, Ma R, Zhang M, et al. <article-title update=\"added\">Nanotherapeutic approaches of interleukin-3 to clear the \u03b1-synuclein pathology in mouse models of Parkinson\u2019s disease. Adv Sci. 2024;11:2405364. https:\/\/doi.org\/10.1002\/advs.202405364.","journal-title":"Adv Sci"},{"key":"3997_CR77","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41419-023-05807-y","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, Ding L, Chen H, Zhang M, Ma R, Zheng S, et al. Cntnap4 partial deficiency exacerbates \u03b1-synuclein pathology through astrocyte-microglia C3-C3aR pathway. Cell Death Dis. 2023;14:285. https:\/\/doi.org\/10.1038\/s41419-023-05807-y.","journal-title":"Cell Death Dis"},{"key":"3997_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300180","volume":"10","author":"M Zhang","year":"2023","unstructured":"Zhang M, Chen H, Zhang W, Liu Y, Ding L, Gong J, et al. Biomimetic remodeling of microglial riboflavin metabolism ameliorates cognitive impairment by modulating neuroinflammation. Adv Sci. 2023;10:e2300180. https:\/\/doi.org\/10.1002\/advs.202300180.","journal-title":"Adv Sci"},{"key":"3997_CR79","doi-asserted-by":"publisher","first-page":"104323","DOI":"10.1016\/j.ebiom.2022.104323","volume":"86","author":"W Zhang","year":"2022","unstructured":"Zhang W, Huang J, Gao F, You Q, Ding L, Gong J, et al. Lactobacillus reuteri normalizes altered fear memory in male Cntnap4 knockout mice. EBioMedicine. 2022;86:104323. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104323.","journal-title":"EBioMedicine"},{"key":"3997_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8340192","volume":"2019","author":"Y Liu","year":"2019","unstructured":"Liu Y, Du T, Zhang W, Lu W, Peng Z, Huang S, et al. <article-title update=\"added\"> Modified Huang-Lian-Jie-Du Decoction ameliorates a \u03b2 synaptotoxicity in a murine model of Alzheimer\u2019s disease. Oxid Med Cell Longev. 2019;2019:1\u201327. https:\/\/doi.org\/10.1155\/2019\/8340192.","journal-title":"Oxid Med Cell Longev"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03997-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03997-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03997-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:29:42Z","timestamp":1770204582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03997-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3997"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03997-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were approved by the Institutional Animal Care and Use Committee of Guangzhou Medical University and were performed in accordance with the guidelines from the National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}